Human medicines European public assessment report (EPAR): Uplizna, inebilizumab, Date of authorisation: 25/04/2022, Revision: 10, Status: Authorised

Summary of opinion: Respivac aMPV (previously Respivac TRT), 21/05/2026 Positive

Scientific and technical recommendations: Veterinary Medicines Regulation

EC request to EMA for guidance on scientific issues in relation to Articles 107(6) and 114(3) of Regulation (EU) 2019/6

Veterinary medicines European public assessment report (EPAR): Nobivac NXT HC, feline calicivirosis and feline viral rhinotracheitis vaccine (live), Status: Opinion

Veterinary medicines European public assessment report (EPAR): Nobivac NXT HCP, felid herpesvirus 1, strain G2620A, live,feline calicivirus, strain F9, live,feline panleucopenia virus, strain MW-1, live, Status: Opinion

Veterinary medicines European public assessment report (EPAR): Nobivac NXT HCPCh, feline calicivirosis, feline rhinotracheitis, feline panleucopenia and feline chlamydiosis (live) vaccine, Status: Opinion

Human medicines European public assessment report (EPAR): Piasky, crovalimab, Date of authorisation: 22/08/2024, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Yttriga, yttrium [90Y] chloride, Date of authorisation: 19/01/2006, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Yuvanci, macitentan,tadalafil, Date of authorisation: 27/09/2024, Revision: 2, Status: Authorised